These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30033178)

  • 1. Bile Acid Deficiency and Constipation.
    Palmer RH
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1363-1364. PubMed ID: 30033178
    [No Abstract]   [Full Text] [Related]  

  • 2. Bile Acids and Bowel Function: Do They Play a Role in Constipation-Associated Irritable Bowel Syndrome?
    Wald A
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):486-487. PubMed ID: 29155167
    [No Abstract]   [Full Text] [Related]  

  • 3. Causal Role of Bile Acids in Irritable Bowel Syndrome-Constipation.
    Hofmann AF
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):213-214. PubMed ID: 30558894
    [No Abstract]   [Full Text] [Related]  

  • 4. Bile acids and dioctyl sodium sulfosuccinate in constipation and irritable colon.
    KING JC
    Am J Gastroenterol; 1961 Jan; 35():50-60. PubMed ID: 13756083
    [No Abstract]   [Full Text] [Related]  

  • 5. The Contributions of Internal Intussusception, Irritable Bowel Syndrome, and Pelvic Floor Dyssynergia to Obstructed Defecation Syndrome.
    Cavallaro PM; Staller K; Savitt LR; Milch H; Kennedy K; Weinstein MM; Ricciardi R; Bordeianou LG
    Dis Colon Rectum; 2019 Jan; 62(1):56-62. PubMed ID: 30451752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply.
    Vijayvargiya P; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1364. PubMed ID: 30033179
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply.
    Camilleri M
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):214. PubMed ID: 30558895
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation.
    Abrahamsson H; Ostlund-Lindqvist AM; Nilsson R; Simrén M; Gillberg PG
    Scand J Gastroenterol; 2008; 43(12):1483-8. PubMed ID: 18788050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
    Tack J
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome.
    Suttor VP; Prott GM; Hansen RD; Kellow JE; Malcolm A
    Dis Colon Rectum; 2010 Feb; 53(2):156-60. PubMed ID: 20087090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing treatment for patients with irritable bowel syndrome with constipation.
    Malagelada JR
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):1-2. PubMed ID: 23859753
    [No Abstract]   [Full Text] [Related]  

  • 12. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
    Johnston JM; Kurtz CB; Macdougall JE; Lavins BJ; Currie MG; Fitch DA; O'Dea C; Baird M; Lembo AJ
    Gastroenterology; 2010 Dec; 139(6):1877-1886.e2. PubMed ID: 20801122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    Nakajima A; Seki M; Taniguchi S
    J Gastroenterol; 2018 Apr; 53(4):525-534. PubMed ID: 28840422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of Roman IIII( criteria in the diagnosis of chronic constipation].
    Fang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Dec; 19(12):1321-1323. PubMed ID: 28000181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients.
    Hofmann AF; Loening-Baucke V; Lavine JE; Hagey LR; Steinbach JH; Packard CA; Griffin TL; Chatfield DA
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):598-606. PubMed ID: 18955863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of irritable bowel syndrome with constipation: a flexible approach to treating a complex condition with multiple symptoms.
    Layer P
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):9-14. PubMed ID: 23859755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging pharmacological therapies for the irritable bowel syndrome.
    Maneerattanaporn M; Chang L; Chey WD
    Gastroenterol Clin North Am; 2011 Mar; 40(1):223-43. PubMed ID: 21333909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kiwifruit improves bowel function in patients with irritable bowel syndrome with constipation.
    Chang CC; Lin YT; Lu YT; Liu YS; Liu JF
    Asia Pac J Clin Nutr; 2010; 19(4):451-7. PubMed ID: 21147704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome and chronic constipation: Fact and fiction.
    Bellini M; Gambaccini D; Usai-Satta P; De Bortoli N; Bertani L; Marchi S; Stasi C
    World J Gastroenterol; 2015 Oct; 21(40):11362-70. PubMed ID: 26523103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for bile acid diarrhoea in suspected irritable bowel syndrome.
    Aziz I; Kurien M; Sanders DS; Ford AC
    Gut; 2015 May; 64(5):851. PubMed ID: 24870624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.